COVID-19 Molecular Structure and Therapeutics Hub for Drug Discovery

A community-driven data repository aggregates molecular structures, models, therapeutics, and simulations related to COVID-19 (SARS-CoV-2). The data is hosted on AWS S3 and was curated by the Molecular Sciences Software Institute (MolSSI) and BioExcel to accelerate computational drug discovery. The dataset's size, row count, and last update date are unknown.

Use Cases

• Perform molecular docking simulations based on provided molecular structures.
• Train predictive models for drug efficacy based on curated therapeutic data.
• Validate computational research hypotheses based on aggregated simulation results.

Strengths

• Data is specifically curated for COVID-19 therapeutic research, providing a focused resource.
• The repository is community-driven, suggesting potential for collaborative vetting and contribution.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.

Provenance

Source

Molecular Sciences Software Institute (MolSSI) and BioExcel

Collection Method

Community-driven aggregation and curation

Time Range

Related to COVID-19 (SARS-CoV-2) research, but specific temporal coverage is unknown.

Freshness

Last update date is unknown.

Geography

Global (research related to a global pandemic), but specific spatial coverage is unknown.